Ver mas grande
ELISA Kit for Docosahexaenoic Acid (DHA)
CC-CEO623Ge
Producto nuevo
48T, 96T, 96T×5, 96T×10, 96T×100
Comprando este producto generará 9 Biopuntos. Su cesta contiene un total 9 Biopuntos puede ser convertido en un Biobonos Descuento 36.00EUR.
Hoja técnica
| Size | 96T |
| Storage Conditions | -20°C |
| Shipping Conditions | Entre 4°C y 8°C |
| Applications | Enzyme-linked immunosorbent assay for Antigen Detection. |
| Detection Range | 12.35-1,000pg/mL |
| Sensitivity | The minimum detectable dose of this kit is typically less than 5.16pg/mL |
| Organism species | Pan-species (General) |
| Alternative Names | Doconexent |
| Item Name | Docosahexaenoic Acid |
| Assay Length | 2h |
| Method | Competitive Inhibition |
| Sample Type | serum, plasma and other biological fluids |
| Formato | 48T, <i>96T</i>, 96T×5, 96T×10, 96T×100 |
| Test Principle | This assay employs the competitive inhibition enzyme immunoassay technique. A monoclonal antibody specific to Docosahexaenoic Acid (DHA) has been pre-coated onto a microplate. A competitive inhibition reaction is launched between biotin labeled Docosahexa |
| Assay procedure summary | 1. Prepare all reagents, samples and standards |
| UniProt ID | - |
Más información
CITATIONS
Clinical Characterization of Serum Docosahexaenoic Acid and Its Relationship With Inflammation Factors in Patients With Diabetic Nephropathy;MYCN and PRC1 cooperatively repress docosahexaenoic acid synthesis in neuroblastoma via ELOVL2;Novel Nanoliposome Codelivered DHA and Anthocyanidin: Characterization, In Vitro Infant Digestibility, and Improved Cell Uptake;